Results 221 to 230 of about 721,111 (291)

Correction: Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials. [PDF]

Front Antibiot
DiNardo AR, Sabiiti W, Gillespie SH, Georghiou SB, Heinrich N, Hittel N, Taghlabi S, Longlax DC, Kohli M, Panzner U, Musia C, Lange C, Vasiliu A, Arts RJW, Mandalakas AM, Ruhwald M, Stuyver LJ, van Crevel R.   +17 more
europepmc   +1 more source

Correction: User Profiles and Engagement in a Hypertension Self-Management App: Cross-Sectional Survey.

J Med Internet Res
Muehlensiepen F, May S, Seifert F, Wengemuth E, Johannsen O, Middeke M, Heinze M, Petit P, Vuillerme N, Spethmann S, Bruch D.   +10 more
europepmc   +1 more source

Comparing emergency medical service and walk-in patients in German emergency departments: a prospective multicentre survey. [PDF]

BMC Emerg Med
Oslislo S, Witt K, Steiger E, Hagelskamp J, von Stillfried D, Katipoglu G, Pfeiffer C, Dommasch M, Klein M, Somasundaram R, Wrede C, Bayeff-Filloff M, Bogner-Flatz V, Herdtle S, Zimmermann M.   +14 more
europepmc   +1 more source

The Many Facets of Workplace Moral Courage: Development and Validation of a Multidimensional Scale

Human Resource Development Quarterly, EarlyView.
ABSTRACT In the battle against unethical behavior in organizations, fostering employees' moral courage proves vital beyond conventional regulation and compliance efforts. To propel this frontier and empower individuals to uphold moral values, a robust measure of workplace moral courage becomes imperative.
Nicole Witt, Carmen Tanner
wiley   +1 more source

High-Grade Urothelial Carcinoma Arising From a Ureteral Diverticulum: A Rare Case Report. [PDF]

IJU Case Rep
Papadopoulos I, Ledderose S, Ebner B, Berg E, Aydogdu C, Marcon J, Bischoff R, Kazmierczak P, Stief CG, Eismann L.   +9 more
europepmc   +1 more source

Improving genetic diagnosis of hereditary tumor syndromes: From expanded gene panels to functional genomics

International Journal of Cancer, EarlyView.
Abstract Genetic tumor risk syndromes (genturis) contribute substantially to the overall cancer burden and provide opportunities for early detection, prevention, and individualized treatment. Yet, many affected individuals remain undiagnosed due to restrictive testing criteria and challenges in variant interpretation.
Mayra Sauer, Morghan C. Lucas, Vitus Prokosch, Thomas Keßler, Thomas Risch, Andreas Laner, Jan Henkel, Anna Benet‐Pagès, Ariane Hallermayr, Verena Steinke‐Lange, Elke Holinski‐Feder, Barbara Klink   +11 more
wiley   +1 more source

Correction: Antipsychotic‑Related Prolactin Changes: A Systematic Review and Dose-Response Meta‑analysis. [PDF]

CNS Drugs
Lin X, Siafis S, Tian J, Wu H, Qin M, Correll CU, Schneider-Thoma J, Leucht S.   +7 more
europepmc   +1 more source

Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancer

International Journal of Cancer, EarlyView.
What's New? While treatment strategies for solid brain metastases have been relatively uniform across cancer subtypes, tailored approaches are warranted. In this observational study, intracranial recurrences after microsurgical resection occurred significantly earlier and more frequently at distant sites in patients with triple‐negative breast cancer ...
Jonathan Weller, Sophie Katzendobler, Frederic Thiele, Anna Riesberg, Patrick N. Harter, Frederick Klauschen, Rachel Wuerstlein, Stephan Schoenecker, Montserrat Pazos Escudero, Robert Forbrig, Niklas Thon, Florian Ringel, Michael Weller, Emilie Le Rhun, Veit M. Stoecklein   +14 more
wiley   +1 more source

Cardiac surgery in an infant hemophilia B carrier with moderate hemophilia: a case report. [PDF]

Front Cardiovasc Med
Hölz J, Nobile C, Holzapfel J, Lieftüchter V, De Winkel N, Olivieri M.   +5 more
europepmc   +1 more source

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

International Journal of Cancer, EarlyView.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, Peter Mohr, Thomas Sickmann, Pia Dücker, Christoffer Gebhardt, Sebastian Haferkamp, Katharina C. Kähler, Friedegund Meier, Claudia Pföhler, Anca Sindrilaru, Patrick Terheyden, Imke von Wasielewski, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Dirk Schadendorf   +18 more
wiley   +1 more source